Accenture
ACN
$250.49
+0.22%
Accenture PLC is the world's largest professional services firm, delivering management and technology consulting, systems integration, and business process outsourcing to enterprises across communications/media/technology, financial services, health and public services, consumer goods, and resources, with roughly 814,000 employees in over 120 countries. Its scale, vendor-neutral multi-partner model, and deep C-suite relationships make it the default global integrator for large-scale enterprise transformation — a position distinct from software pure-plays and smaller regional IT services rivals. The current investor narrative is a violent tug-of-war: bears point to a brutal mid-2026 drawdown (shares fell roughly 50% year-to-date by late June on fears of U.S. federal contract losses and generative-AI disintermediation of billable consulting hours), while bulls seized on the Q4 FY26 beat reported October 1 — revenue of $18.68B (+6.15% YoY), EPS of $3.31, and management commentary that AI demand is broadening into FY27 — to drive a roughly 100% rally off the June lows. The debate now centers on whether Accenture is an AI winner monetizing enterprise reinvention at scale or a structurally challenged labor-arbitrage model, with the stock's extraordinary round-trip volatility reflecting genuine two-sided conviction.…
ACN
Accenture
$250.49
Related headlines
Investment Opinion: Should I buy ACN Today?
Rating: Hold with a constructive bias. Accenture is a fortress-balance-sheet, 26.51%-ROE franchise trading at 13.89x trailing and roughly 13.4x consensus FY EPS of $19.43 — near the very bottom of its 12.9x-37.1x historical band — but the 113% rally off the $124.44 June low to $260.50 has already captured much of the easy re-rating, and the Hold-heavy analyst consensus (five of ten at Hold/Neutral, including Baird's October 21 downgrade from Outperform) argues against chasing at 96.8% of the 52-week range. The core thesis: you are being paid a ~10% FCF yield ($11.62B TTM FCF on a $116.2B market cap) and a 3.43% dividend yield to underwrite whether AI expands or cannibalizes Accenture's billable-hours model — a binary question the current multiple does not fully resolve either way.
Supporting evidence is genuinely strong on quality and cheap on price. Valuation: 13.89x trailing PE and 8.32x EV/EBITDA sit roughly 25-45% below the 18x-25x typical of IT services peers, with PS at 1.57x versus historical readings of 6.1x-15.1x. Growth: Q4 FY26 revenue of $18.68B grew 6.15% YoY, and consensus FY revenue of $98.85B implies ~6-7% — steady but not accelerating. Profitability: gross margin recovered from a 30.26% Q2 trough to 32.77% in Q3 and 32.04% in Q4, with Q4 operating margin of 15.33% and full-year net margin of 11.28%. Balance sheet and cash: debt-to-equity of 0.42, current ratio of 1.43, 27.6x interest coverage, $12.83B cash, and $2.33B of Q4 buybacks plus $974M of dividends. The tight EPS dispersion ($18.98-$19.99, a ~5% spread) confirms the uncertainty is in the multiple, not the earnings.
Three risks could invalidate the thesis: (1) AI disintermediation — if AI-native competitors like Palantir demonstrate software-like scalability on enterprise transformation work, the labor-arbitrage model de-rates further rather than re-rates; (2) renewed U.S. federal contract losses, the trigger of the June collapse, which could retest the $124.44 low (-52%); (3) momentum reversal after a 48.25% three-month run with 1-year relative strength still -1.65 versus SPY's +9.59%. This Hold would upgrade to Buy on a pullback toward the $212-$215 breakout shelf (implying ~12x forward EPS) or on evidence of AI bookings converting into accelerating consulting revenue above 8% growth; it would downgrade to Sell if revenue growth decelerates below 5% or gross margin breaks back below 30%. Verdict: fairly valued to modestly undervalued versus history and peers, but no longer the generational entry it was at $124.
Sign up to view all
ACN 12-Month Price Forecast
Accenture presents a genuinely two-sided setup: a high-quality franchise at a historically depressed 13.89x multiple with a ~10% FCF yield, but with mid-single-digit growth and a binary AI question that the market has not resolved. The 113% rally off the June low has already closed much of the valuation gap, and the Hold-heavy consensus plus Baird's post-rally downgrade suggest near-term upside is largely captured. The base case (55% probability, $240-$285) assumes 6-7% growth and a stable 13x-15x multiple, with the bull case (20%, $310-$340) requiring AI bookings to convert into accelerating revenue and multiple expansion, and the bear case (25%, $125-$190) pricing renewed federal losses or AI-driven deceleration. I would upgrade to bullish on a pullback toward $212-$215 (~12x forward EPS) or on evidence of AI-driven revenue acceleration above 8%, and downgrade to bearish if growth decelerates below 5% or gross margin breaks below 30%.
Wall Street consensus
Ten analysts cover Accenture, and the consensus is decidedly neutral-to-cautious: the institutional ratings show a heavy skew toward Hold/Neutral/Equal Weight (Wells Fargo, Baird, Susquehanna, TD Cowen, Truist all at Hold/Neutral/Equal Weight) with only a minority at Buy/Outperform (Goldman Sachs, RBC Capital, Mizuho). The consensus EPS estimate of $19.43 (range $18.98-$19.99) and revenue estimate of $98.85B (range $97.09B-$101.04B) imply roughly 6-7% growth, consistent with the recent trajectory. Notably, Baird downgraded from Outperform to Neutral on October 21 — after the stock had already rallied sharply — suggesting analysts view the post-earnings move as having captured much of the near-term upside; the absence of a published average price target in the data prevents calculating precise implied upside, but the Hold-heavy distribution signals the consensus sees the stock as fairly valued after its run. The target range is not explicitly provided, but the EPS dispersion ($18.98 low to $19.99 high, a ~5% spread) is tight, indicating strong conviction in near-term earnings — the uncertainty is in the multiple, not the fundamentals. The high end of estimates ($19.99 EPS, $101.04B revenue) would require AI-driven consulting reacceleration and multiple expansion toward the mid-teens PE, while the low end ($18.98 EPS, $97.09B revenue) prices in continued mid-single-digit growth with no re-rating and possible margin pressure from AI investment. The pattern of recent ratings — mostly reiterations at Hold with one downgrade — points to a wait-and-see stance: analysts acknowledge the strong Q4 beat and broadening AI demand but are unwilling to chase the stock near its 52-week high until they see evidence that AI is expanding rather than cannibalizing the billable-hours model.
Bulls vs Bears: ACN Investment Factors
The bear case currently has slightly stronger near-term evidence: growth is stuck at 6.15%, the analyst consensus is Hold-heavy with a fresh Baird downgrade after the rally, and the stock is up 113% from its June low and sitting at 96.8% of its 52-week range with negative 1-year relative strength. The bull case rests on genuinely compelling valuation — 13.89x trailing PE versus a low-to-mid-20s historical average, a ~10% FCF yield, 26.51% ROE and expanding gross margins — plus a Q4 beat and broadening AI demand into FY27. The single most important tension is whether AI is a net expander or a cannibalizer of Accenture's billable-hours model: if AI bookings convert into incremental consulting and outsourcing revenue, the 13.89x multiple is a generational entry point; if AI compresses billable hours faster than Accenture can reprice, the discount is a value trap. Everything else — the federal contract losses, the margin trend, the analyst stance — is downstream of that one question.
Bullish
- Valuation near multi-year lows: At $260.50 the stock trades at 13.89x trailing PE and ~13.4x the $19.43 consensus FY EPS, versus a historical PE band of roughly 12.9x-37.1x with a low-to-mid-20s multi-year average. The 1.57x PS ratio compares with historical readings of 6.1x-15.1x, and 8.32x EV/EBITDA sits below the 18x-25x PE range typical of IT services peers — a 25-45% discount that leaves room for multiple normalization.
- Fortress balance sheet and 10% FCF yield: Debt-to-equity of just 0.42, a 1.43 current ratio, 27.6x interest coverage and $12.83B of cash underpin the balance sheet. TTM free cash flow of $11.62B against a $116.2B market cap implies roughly a 10% FCF yield, and FY26 capital returns were aggressive ($2.33B buybacks and $974M dividends in Q4 alone).
- Margins expanding through the cycle: Gross margin recovered from a 30.26% Q2 trough to 32.77% in Q3 and 32.04% in Q4, while Q4 operating margin reached 15.33% and EBITDA margin 18.77%. Net margin of 10.66% in Q4 and 11.28% for the full year, with 26.51% ROE, show pricing power holding even as AI investment ramps.
- Q4 beat and broadening AI demand: Q4 FY26 revenue of $18.68B grew 6.15% YoY and EPS of $3.31 beat expectations, driving a ~100% rally off the June low of $124.44. Management commentary that AI demand is broadening into FY27, echoed in the October 2 earnings-call coverage, is the catalyst behind the re-rating.
Bearish
- Growth stuck in mid-single digits: Revenue growth of 6.15% YoY is unremarkable for a franchise the market once valued at 20x+ earnings, and the quarterly run-rate of $18.0B-$18.7B shows no acceleration. Consensus FY revenue of $98.85B implies only ~6-7% growth, meaning the October rally was driven by narrative and margin optimism rather than top-line reacceleration.
- AI disintermediation threat is real: The June collapse to $124.44 was triggered by fears that generative AI cannibalizes billable consulting hours, and the Motley Fool's June 27 piece confirmed real federal contract losses alongside the AI automation fear. Palantir's software-like scalability versus consulting economics (October 8 coverage) highlights the structural margin gap the labor-arbitrage model faces.
- Analyst consensus is Hold-heavy: Of ten covering analysts, five sit at Hold/Neutral/Equal Weight (Wells Fargo, Baird, Susquehanna, TD Cowen, Truist) versus only three at Buy/Outperform. Baird downgraded from Outperform to Neutral on October 21 after the rally, signaling the consensus believes the post-earnings move has captured near-term upside.
- Extreme volatility and overextension: The stock has a -56.87% maximum drawdown and traveled 113% from the June 30 low of $124.44 to the November 5 high of $265.16. At $260.50 it sits at 96.8% of its 52-week range, up 32.48% in one month and 48.25% in three, with the most recent session down 1.76% — classic stalling-momentum risk near prior highs.
ACN Technical Analysis
Accenture is in a powerful recovery uptrend following a severe bear phase, with the stock up 7.94% over the past year but having traveled from a 52-week closing low of $124.44 (June 30) to a recent high of $265.16 (November 5) — a roughly 113% advance off the trough. At the current $260.50, the stock sits at approximately 96.8% of its 52-week range, just below the highs, signaling strong momentum but also meaningful overextension risk after such a vertical move. The 1-year gain of 7.94% masks the violence of the path: a maximum drawdown of -56.87% followed by a near-full retracement, a classic V-shaped recovery that typically leaves the stock vulnerable to profit-taking near prior highs. Short-term momentum is decisively positive and accelerating: the stock is up 32.48% over the past month and 48.25% over three months, dramatically outpacing the S&P 500's -4.99% and -4.91% respective returns, producing relative strength readings of +37.47 (1-month) and +53.16 (3-month). This contrasts sharply with the 1-year relative strength of -1.65 versus SPY's +9.59%, meaning Accenture has only just caught up to the market after a year of underperformance — the divergence between explosive 3-month leadership and flat 1-year performance suggests the move is a re-rating off depressed expectations rather than a durable multi-year trend, and the most recent session's -1.76% pullback from $265.16 hints at stalling momentum at the highs. Key resistance sits at the $265.16 recent high, with a breakout above it opening the door to new all-time-high territory and confirming the recovery as a genuine trend reversal; support is layered at the $235-$240 zone (late-October consolidation) and, more critically, the $212-$215 breakout shelf from early October, with a failure there exposing the $183-$190 September range. The stock's beta is not available in the provided data, but the -56.87% max drawdown and 113% trough-to-peak swing are prima facie evidence of far-above-market volatility, warranting smaller position sizing and wider stops than a typical large-cap technology holding.
Beta
—
—
Max Drawdown
-56.9%
Largest decline past year
52-Week Range
—
Price range past year
Annual Return
+1.2%
Cumulative gain past year
| Period | ACN Return | S&P 500 |
|---|---|---|
| 1m | +16.5% | -2.3% |
| 3m | +41.6% | -2.8% |
| 6m | +48.4% | +2.1% |
| 1y | +1.2% | +12.3% |
| ytd | -3.6% | +10.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ACN Fundamental Analysis
Accenture's revenue trajectory is steady but modest: Q4 FY26 revenue of $18.68B grew 6.15% year-over-year versus $17.60B in Q4 FY25, and the trailing four quarters show a consistent $18.0B-$18.7B quarterly run-rate (Q1 $18.74B, Q2 $18.04B, Q3 $18.72B, Q4 $18.68B) with no evidence of acceleration — growth is stable in the mid-single digits rather than compounding. The business is remarkably balanced, with consulting revenue of $18.70B and outsourcing revenue of $18.73B splitting the top line almost exactly 50/50, meaning the managed-services annuity provides a ballast against cyclical consulting demand. The key fundamental tension is that 6.15% growth is unremarkable for a company trading at a premium multiple, and the market's October re-rating was driven more by margin and AI-narrative optimism than by top-line reacceleration. Profitability remains robust and is improving: Q4 FY26 net income was $1.99B on a 10.66% net margin, with gross margin at 32.04% and operating margin at 15.33%, and the quarterly progression shows gross margin expanding from 30.26% in Q2 to 32.77% in Q3 to 32.04% in Q4 — a clear upward trend from the 30.26% Q2 trough. Net margin similarly recovered from 10.30% in Q2 to 12.50% in Q3 before settling at 10.66% in Q4, and the full-year net margin of 11.28% is consistent with a mature services model where scale and utilization drive returns. The margin story is the bull case's strongest leg: operating margin of 15.33% and EBITDA margin of 18.77% in Q4 demonstrate pricing power and cost discipline even as AI investment ramps. The balance sheet is a fortress: debt-to-equity of just 0.42, a current ratio of 1.43, and trailing free cash flow of $11.62B against a $116.2B market cap imply an FCF yield of roughly 10% — exceptionally high for a large-cap technology services firm. ROE of 26.51% is strong, interest coverage of 27.6x is comfortable, and the company returned capital aggressively in FY26 (Q4 alone: $2.33B buybacks and $974M dividends) while still growing cash to $12.83B. The one blemish is the Q4 operating cash flow of $3.10B versus $3.91B in the prior-year Q4, reflecting working-capital timing, but the TTM FCF of $11.62B and 91.9% FCF conversion of operating cash flow confirm the business funds itself internally with room to spare.
Quarterly Revenue
$18.7B
2026-08
Revenue YoY Growth
+6.2%
YoY Comparison
Gross Margin
32.0%
Latest Quarter
Free Cash Flow
$11.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ACN Overvalued?
Because Accenture is solidly profitable (Q4 net income of $1.99B), the PE ratio is the appropriate primary metric, and the trailing PE of 13.89x against a forward PE of just 1.25x is a striking anomaly that almost certainly reflects a data artifact — the forward figure appears to be a PEG ratio mislabeled as forward PE, since a 1.25x forward multiple on $19.43 consensus EPS would imply a ~$24 stock price, which is nonsensical against the $260.50 quote. Using the more reliable trailing PE of 13.89x and the consensus FY EPS estimate of $19.43, the stock trades at roughly 13.4x forward earnings — a genuinely low multiple for a franchise business, and the gap between the 13.89x trailing and ~13.4x forward multiples implies the market is pricing only modest earnings growth, not the AI-driven acceleration bulls expect. Against the information technology services industry, Accenture's 13.89x trailing PE and 8.32x EV/EBITDA are at or below typical sector levels (IT services peers often trade in the 18x-25x PE range), representing a meaningful discount of roughly 25-45% — a discount that is only partially justified by the company's mid-single-digit growth and AI disruption fears, and which the October rally has begun to close. The 1.57x PS ratio and 3.68x PB ratio are also modest for a business with 26.5% ROE and 11.3% net margins, reinforcing that the stock is not expensive on absolute or relative grounds. Historically, Accenture's PE has ranged from roughly 12.9x (Q3 FY26) to 37.1x (Q4 FY23), with the multi-year average in the low-to-mid 20s; the current 13.89x sits near the very bottom of that band, comparable only to the June 2026 panic lows. The PS ratio tells the same story: 1.57x today versus historical readings of 6.1x-15.1x over the past several years, an extreme compression that reflects both the price collapse and the market's reassessment of growth durability. This positioning near historical valuation lows suggests either a compelling value opportunity if the AI-demand narrative proves durable, or a value trap if structural disintermediation erodes the consulting model — the October re-rating indicates the market is beginning to lean toward the former.
PE
13.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 13x~37x
vs. Industry Avg
19.1x
Industry PE ~19.1x*
EV/EBITDA
8.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on a business that must keep growing to justify even its depressed multiple. Revenue growth of 6.15% YoY with a flat $18.0B-$18.7B quarterly run-rate leaves little cushion, and Q4 operating cash flow of $3.10B came in below the prior-year Q4's $3.91B on working-capital timing, a reminder that cash conversion can wobble. The 50/50 consulting/outsourcing split cuts both ways: outsourcing provides annuity ballast but carries structurally lower margins, and any pricing pressure from AI-enabled delivery would hit the 32.04% gross margin and 15.33% operating margin directly. The balance sheet itself is not the risk — debt-to-equity of 0.42, a 1.43 current ratio and 27.6x interest coverage are fortress-grade — but the payout ratio of 47.65% and $2.33B of quarterly buybacks mean capital returns are sized for continued earnings growth, not a stall. Market and competitive risks are dominated by multiple compression and AI disruption. At 13.89x trailing PE the stock is cheap versus its own low-to-mid-20s history, but that discount exists because the market doubts the durability of the labor-arbitrage model; if AI-native competitors such as Palantir demonstrate software-like scalability on enterprise transformation work, Accenture's vendor-neutral integrator position could be disintermediated rather than enhanced. The stock's -56.87% max drawdown and 113% trough-to-peak swing are prima facie evidence of far-above-market volatility even without a reported beta, and the -1.65 one-year relative strength versus SPY's +9.59% shows how quickly sentiment can reverse. Regulatory and political risk is concentrated in U.S. federal contracts, where the June drawdown originated, and sector rotation out of IT services into AI software pure-plays remains a persistent overhang. The worst-case scenario is a repeat of the June 2026 chain: renewed evidence of federal contract losses plus an AI-driven deceleration in consulting bookings, which would compress the multiple back toward the 12.9x Q3 FY26 trough and could retest the $124.44 52-week low — roughly -52% from the current $260.50. A less severe but more probable adverse path is a retracement to the $212-$215 early-October breakout shelf (-17% to -18%) or the $183-$190 September range (-27% to -30%) if the post-earnings momentum fades and analysts capitulate further. Given the stock is up 48.25% in three months and sits 1.76% off its high, position sizing should assume a realistic 20-30% drawdown is a normal correction, not a tail event.
FAQ
Ranked by severity: first, AI disintermediation — if AI-native competitors such as Palantir demonstrate software-like scalability on enterprise transformation work, Accenture's billable-hours model de-rates rather than re-rates, and this is the single factor that most changes the thesis. Second, U.S. federal contract risk — the June 2026 collapse to $124.44 originated in real federal contract losses, and a recurrence could retest that low, roughly -52% from $260.50. Third, growth and margin risk — revenue growth of 6.15% YoY with a flat $18.0B-$18.7B quarterly run-rate leaves little cushion, and any pricing pressure from AI-enabled delivery would hit the 32.04% gross margin and 15.33% operating margin directly; Q4 operating cash flow of $3.10B also came in below the prior-year Q4's $3.91B on working-capital timing. Fourth, valuation and momentum risk — after a 48.25% three-month run with 1-year relative strength still -1.65 versus SPY's +9.59%, a momentum unwind or further analyst downgrades could compress the multiple back toward the 12.9x Q3 FY26 trough, with a realistic 20-30% drawdown being a normal correction rather than a tail event.
The 12-month forecast is scenario-weighted: base case 55% probability, $240-$285, assuming 6-7% revenue growth consistent with the $98.85B consensus and $19.43 EPS, gross margin near 32%, and a stable 13x-15x multiple as the stock consolidates its 113% rally between the $235-$240 support and the $265.16 high. Bull case 20% probability, $310-$340, requires AI bookings to convert into revenue growth above 8% and the multiple to re-rate toward 16x-18x on FY27 EPS near $20.50-$21.00, with a breakout above $265.16 confirming a genuine trend reversal. Bear case 25% probability, $125-$190, prices renewed federal contract losses or AI-driven deceleration below 5% growth, compressing the multiple back toward 12.9x and retracing through the $212-$215 breakout shelf and the $183-$190 September range, with a tail scenario retesting the $124.44 low. The base case is most likely, and its key assumption is that AI demand broadens into FY27 without cannibalizing billable hours and without further material federal contract losses.
ACN screens as fairly valued to modestly undervalued versus its own history and peers. The trailing PE of 13.89x and roughly 13.4x forward multiple on $19.43 consensus EPS sit near the very bottom of the 12.9x-37.1x historical band, whose multi-year average is in the low-to-mid 20s, and the 8.32x EV/EBITDA and 1.57x PS ratio (versus historical PS readings of 6.1x-15.1x) are well below the 18x-25x PE range typical of IT services peers — a 25-45% discount. That discount is only partially justified by 6.15% growth and AI disruption fears, and the October re-rating has begun to close it. Note that the reported 1.25x forward PE is almost certainly a data artifact (it appears to be the PEG ratio mislabeled), since it would imply a ~$24 stock price. What the valuation implies is that the market expects only modest earnings growth and doubts the durability of the labor-arbitrage model — if AI proves net-accretive, the multiple has substantial room to normalize; if it proves cannibalistic, the discount is a value trap.
From a risk/reward perspective, ACN offers an asymmetric setup only at the right price: at $260.50 it trades at 13.89x trailing and roughly 13.4x consensus FY EPS of $19.43, near the bottom of its 12.9x-37.1x historical band and 25-45% below typical IT services peers, while a ~10% FCF yield ($11.62B TTM FCF) and 3.43% dividend yield pay you to wait. The upside case rests on multiple normalization toward the mid-teens on FY27 EPS near $20.50-$21.00 (bull case $310-$340, 20% probability), but the stock has already rallied 113% off the $124.44 June low and sits at 96.8% of its 52-week range, with a Hold-heavy analyst consensus and Baird's October 21 downgrade suggesting near-term upside is largely captured. The biggest downside risk is a retest of the $124.44 low (-52%) if federal contract losses recur or AI compresses billable hours faster than Accenture can reprice. It is a good buy for valuation-disciplined, long-horizon investors on a pullback toward the $212-$215 breakout shelf (~12x forward EPS) or on evidence of AI-driven revenue acceleration above 8%; it is less attractive for momentum buyers chasing at current levels.
ACN is better suited to long-term holding than short-term trading. It is a mature, mid-single-digit-growth franchise (6.15% YoY revenue growth) with a 3.43% dividend yield, a 47.65% payout ratio, and a fortress balance sheet (0.42 debt-to-equity, 1.43 current ratio, 27.6x interest coverage), which supports a multi-year compounding thesis rather than a momentum trade. However, its volatility profile is far above a typical large-cap: a -56.87% max drawdown and a 113% trough-to-peak swing, with 1-month relative strength of +37.47 versus SPY but 1-year relative strength of -1.65, mean short-term entries carry substantial timing risk. Earnings visibility is high — the tight $18.98-$19.99 EPS dispersion (a ~5% spread) confirms the uncertainty is in the multiple, not the fundamentals — which favors patient ownership. A concrete suggested minimum holding period is 2-3 years, ideally entered on a pullback toward $212-$215 (~12x forward EPS) rather than at 96.8% of the 52-week range, with position sizing that assumes a 20-30% drawdown is a normal correction.

